000 01099 a2200277 4500
005 20250516221544.0
264 0 _c20140928
008 201409s 0 0 eng d
022 _a1873-3735
024 7 _a10.1016/j.tips.2014.05.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGeahlen, Robert L
245 0 0 _aGetting Syk: spleen tyrosine kinase as a therapeutic target.
_h[electronic resource]
260 _bTrends in pharmacological sciences
_cAug 2014
300 _a414-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aIntracellular Signaling Peptides and Proteins
_xantagonists & inhibitors
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aSyk Kinase
773 0 _tTrends in pharmacological sciences
_gvol. 35
_gno. 8
_gp. 414-22
856 4 0 _uhttps://doi.org/10.1016/j.tips.2014.05.007
_zAvailable from publisher's website
999 _c23963071
_d23963071